Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer

NCT02317705 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: OTL38
DEVICE: Near infrared camera imaging system
PROCEDURE: Laparotomy

Sponsor

On Target Laboratories, LLC

Collaborators

[object Object]